Clinical trial
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on…
NCT00048048 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048048 |
|---|---|
| Title | A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. |
| Official title | An Open-label, Randomized, Multi-centre, Multiple Dose Trial to Investigate the Efficacy and Safety of Subcutaneous Injections of RO0503821 at Different Dosing Intervals in Patients With Chronic Renal Anemia Who Are Not on Renal Replacement Therapy |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 65 |
| Start date | Mar 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Nov 1, 2004 |
| First posted | Oct 25, 2002 |
| Last update posted | Jan 2, 2018 |
| Countries | Canada, Mexico, Poland, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: